Sunmax Biotechnology (Taiwan) Price Prediction
| 4728 Stock | TWD 278.00 2.00 0.72% |
Oversold Vs Overbought
60
Oversold | Overbought |
Using Sunmax Biotechnology hype-based prediction, you can estimate the value of Sunmax Biotechnology Co from the perspective of Sunmax Biotechnology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Sunmax Biotechnology to buy its stock at a price that has no basis in reality. In that case, they are not buying Sunmax because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Sunmax Biotechnology after-hype prediction price | TWD 278.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sunmax |
Sunmax Biotechnology After-Hype Price Prediction Density Analysis
As far as predicting the price of Sunmax Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sunmax Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Sunmax Biotechnology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Sunmax Biotechnology Estimiated After-Hype Price Volatility
In the context of predicting Sunmax Biotechnology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sunmax Biotechnology's historical news coverage. Sunmax Biotechnology's after-hype downside and upside margins for the prediction period are 276.68 and 279.32, respectively. We have considered Sunmax Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Sunmax Biotechnology is very steady at this time. Analysis and calculation of next after-hype price of Sunmax Biotechnology is based on 3 months time horizon.
Sunmax Biotechnology Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Sunmax Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sunmax Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sunmax Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.07 | 1.32 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
278.00 | 278.00 | 0.00 |
|
Sunmax Biotechnology Hype Timeline
Sunmax Biotechnology is presently traded for 278.00on Taiwan OTC Exchange of Taiwan. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Sunmax is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at -0.07%. %. The volatility of related hype on Sunmax Biotechnology is about 0.0%, with the expected price after the next announcement by competition of 278.00. About 41.0% of the company shares are owned by insiders or employees . The company recorded earning per share (EPS) of 9.24. Sunmax Biotechnology last dividend was issued on the 13th of July 2022. Assuming the 90 days trading horizon the next anticipated press release will be in 5 to 10 days. Check out Sunmax Biotechnology Basic Forecasting Models to cross-verify your projections.Sunmax Biotechnology Related Hype Analysis
Having access to credible news sources related to Sunmax Biotechnology's direct competition is more important than ever and may enhance your ability to predict Sunmax Biotechnology's future price movements. Getting to know how Sunmax Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sunmax Biotechnology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 2028 | Wei Chih Steel | 0.00 | 0 per month | 0.00 | (0.09) | 2.83 | (2.85) | 13.88 | |
| 2017 | Quintain Steel Co | 0.00 | 0 per month | 0.00 | (0.15) | 1.67 | (1.68) | 10.82 | |
| 1213 | Oceanic Beverages Co | 0.00 | 0 per month | 0.00 | (0.08) | 2.54 | (2.44) | 8.12 | |
| 2228 | Iron Force Industrial | 0.00 | 0 per month | 1.83 | 0.02 | 5.08 | (2.89) | 14.58 | |
| 2867 | Mercuries Life Insurance | 0.00 | 0 per month | 0.00 | (0.19) | 2.30 | (2.03) | 8.83 | |
| 3296 | Powertech Industrial Co | 0.00 | 0 per month | 2.51 | 0.04 | 3.96 | (4.53) | 14.53 | |
| 6624 | Ever Clear Environmental Eng | 0.00 | 0 per month | 0.00 | (0.21) | 0.92 | (1.68) | 5.96 | |
| 3441 | Unique Optical Industrial | 0.00 | 0 per month | 0.00 | (0.06) | 4.67 | (3.95) | 14.13 |
Sunmax Biotechnology Additional Predictive Modules
Most predictive techniques to examine Sunmax price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sunmax using various technical indicators. When you analyze Sunmax charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Sunmax Biotechnology Predictive Indicators
The successful prediction of Sunmax Biotechnology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Sunmax Biotechnology Co, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Sunmax Biotechnology based on analysis of Sunmax Biotechnology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Sunmax Biotechnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Sunmax Biotechnology's related companies.
Story Coverage note for Sunmax Biotechnology
The number of cover stories for Sunmax Biotechnology depends on current market conditions and Sunmax Biotechnology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sunmax Biotechnology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sunmax Biotechnology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Sunmax Biotechnology Short Properties
Sunmax Biotechnology's future price predictability will typically decrease when Sunmax Biotechnology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sunmax Biotechnology Co often depends not only on the future outlook of the potential Sunmax Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sunmax Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 54.5 M |
Additional Tools for Sunmax Stock Analysis
When running Sunmax Biotechnology's price analysis, check to measure Sunmax Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunmax Biotechnology is operating at the current time. Most of Sunmax Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sunmax Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunmax Biotechnology's price. Additionally, you may evaluate how the addition of Sunmax Biotechnology to your portfolios can decrease your overall portfolio volatility.